CD9 and neoplasm: Therefore, the role of CD9 in determining SLN status seems interesting, as also confirmed by Erovic et al. [46] showing that this tetraspanin is a valid marker for lymphatic endothelial cells and able to promote transmigration of tumor cells through the adherence to lymphatic vessels (Figure 1).